Hereditary Cancer: State of the Art
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 44
Special Issue Editors
Interests: cancer genetics; colorectal cancer; hereditary/familial cancers; oesophagus cancer; stomach cancer
Interests: hereditary cancer
Interests: young-onset colorectal cancer; fecal microbiota transplantation; digestive oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Around 10-20% of cancers are hereditary in nature with the presence of pathogenic variants. Interdisciplinary collaboration is essential to provide comprehensive clinical care. Despite the breakthroughs in genomics, artificial intelligence, and targeted therapies in recent years, gaps in the clinical care of families with hereditary cancer syndromes persist. Further advances in providing equitable care in genomic medicine, ethical considerations and therapeutic innovations call for collective action. We invite all stakeholders to contribute their work to this Special Issue, which seeks to put hereditary cancer research and practice under the spotlight. By sharing your insights, we can advance precision oncology and genomic medicine for inherited cancers, with the hope of instigating improvements in patient outcomes. Submissions on topics including, but not limited to, novel gene discovery, artificial intelligence, addressing disparities in genomic medicine, ethical challenges, and emerging therapies are welcome. We aim to transform discoveries in cancer genetics and genomics into tangible solutions for patients and families worldwide.
Dr. Joanne Ngeow
Dr. Jianbang Chiang
Dr. Rashid N. Lui
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hereditary cancer syndromes
- inherited cancers
- cancer genetics and genomics
- germline variants
- surveillance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
